NCT00689494

Brief Summary

Measure blood progesterone by using cervical device contraception.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for phase_1 healthy

Timeline
Completed

Started Jun 2008

Longer than P75 for phase_1 healthy

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2008

Completed
13 days until next milestone

Study Start

First participant enrolled

June 1, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2008

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
Last Updated

June 3, 2008

Status Verified

June 1, 2008

Enrollment Period

6 months

First QC Date

May 19, 2008

Last Update Submit

June 2, 2008

Conditions

Healthy

Keywords

Nanopaz deviceBlood progesterone measure in using the deviceDelivery progesteroneProgesterone levonorgestrel

Outcome Measures

Primary Outcomes (1)

  • blood progesterone measure in blood

    one to two months

Interventions

Nanopaz contraception deviceOTHER

levonorgestrel and levonorgestrel device for cervical contraception-nantechnolgy method

Also known as: levonorgestrel device for cervical contraception-nantechnolgy method

Eligibility Criteria

Age1 Month - 2 Months
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • healthy women are candidate for hysterectomy

You may not qualify if:

  • Women with neoplastic malignancy disease or thrombophylia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

May 19, 2008

First Posted

June 3, 2008

Study Start

June 1, 2008

Primary Completion

December 1, 2008

Study Completion

May 1, 2010

Last Updated

June 3, 2008

Record last verified: 2008-06